Jul 09, 2026
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.05 to $2.40.
The split itself did not change the total investment value.
Qinghai Biotech Pharmaceutical Group Limited (HKEX:876) operates in the Medical specialties industry.
Qinghai Biotech Pharmaceutical Group Limited company overviewQinghai Biotech Pharmaceutical Group Limited's most recent stock split was on July 9, 2026. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
Qinghai Biotech Pharmaceutical Group Limited (HKEX:876) has split its stock 7 times: a 1-for-5 reverse split on November 12, 2001, a 16-for-13 split on January 29, 2002, a 1-for-4 reverse split on April 4, 2003, a 3-for-1 split on February 1, 2005, a 2-for-1 split on January 17, 2006, a 8-for-1 split on October 9, 2014, and a 1-for-50 reverse split on July 9, 2026.
Qinghai Biotech Pharmaceutical Group Limited has split its stock 7 times. This history records 7 splits between November 12, 2001 and July 9, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Qinghai Biotech Pharmaceutical Group Limited's 1-for-50 reverse split on July 9, 2026, every 50 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Qinghai Biotech Pharmaceutical Group Limited has not announced a new split in our records. Its most recent split was on July 9, 2026, less than a year ago. Companies announce splits in advance, and any new HKEX:876 split will appear on this page.
Already premium?